Dettlaff-Pokora A, Matuszewski M, Schlichtholz B
Department of Biochemistry, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.
Cancer Lett. 2005 May 10;222(1):83-8. doi: 10.1016/j.canlet.2004.09.004.
Telomerase is extensively investigated as potential diagnostic and prognostic marker in human tumors. In this study, we determined telomerase activity in histological specimens and voided urine of 52 human bladder cancers. Using the PCR-ELISA method telomerase activity was found in 21 (88%) of the 24 tumor tissues and in the corresponding sediments from voided urine of patients with superficial bladder carcinoma (Ta/T1). In case of muscle-invasive tumors (T2-T4), telomerase activity was found in 27 (96%) of the 28 tumor tissues and in 26 (93%) of the 28 urine sediments. Enzyme activity was not detected in 13 control urine sediments. Telomerase activity was not significantly associated with clinicopathological parameters supporting the diagnostic rather than prognostic value of this marker in bladder cancer. The present study demonstrates that telomerase activity detection in voided urine has high potential for noninvasive diagnosis of superficial bladder tumors.
端粒酶作为人类肿瘤潜在的诊断和预后标志物受到广泛研究。在本研究中,我们测定了52例人类膀胱癌组织标本及晨尿中的端粒酶活性。采用PCR-ELISA法,在24例肿瘤组织中的21例(88%)以及浅表性膀胱癌(Ta/T1)患者晨尿相应沉淀物中检测到端粒酶活性。对于肌层浸润性肿瘤(T2-T4),28例肿瘤组织中的27例(96%)以及28例尿沉淀物中的26例(93%)检测到端粒酶活性。13份对照尿沉淀物中未检测到酶活性。端粒酶活性与临床病理参数无显著相关性,这支持了该标志物在膀胱癌中具有诊断而非预后价值。本研究表明,检测晨尿中端粒酶活性对浅表性膀胱肿瘤的无创诊断具有很大潜力。